YOLFTbeta
Qlife Holding AB

Qlife Holding AB

QLIFE · ST · Healthcare / Medical Devices

1.00SEK+0.02 (+2.04%)

Price History

Full chart

Market Stats

Previous Close0.98
Open0.96
Day Range0.955 – 1.03
52-Week Range1.01 – 3.80
Volume17.82K
Market Cap46.20M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.39
Dividend Yield0.00%
Beta0.60
50-Day Avg1.77
200-Day Avg1.99

About

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Qlife Holding AB (publ) was incorporated in 2019 and is based in Gothenburg, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Thomas Warthoe
  • Employees2
  • HeadquartersUllevigatan 19, Gothenburg, Sweden, 411 40, Sweden
  • Websitehttps://www.qlifeholding.com

Leadership

  • Mr. Thomas WarthoeCo-Founder & CEO · b. 1967
  • Mr. Lars BangsgaardCo-Founder & CFO · b. 1953
  • Mr. Peter WarthoeCo-Founder & Chief Scientific Officer · b. 1967

Financials

Income Statement

Currency: SEK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue11.62M20.75M39.61M17.99M244.00K50.00K324.00K
Growth (%)-+78.63%+90.91%-54.58%-98.64%-79.51%+548.00%
Cost of Revenue1.87M-14.93M-4.93M28.74M6.56M208.00K18.44M
Gross Profit9.74M35.68M44.54M-10.75M-6.31M-158.00K-18.11M
Gross Margin83.89%171.97%112.44%-59.74%-2586.89%-316.00%-5590.74%
Operating Expense14.78M67.01M88.41M84.99M162.38M12.77M1.27M
Operating Income-5.03M-31.32M-43.87M-95.74M-168.70M-12.93M-19.38M
Operating Margin-43.31%-150.96%-110.74%-532.07%-69138.11%-25856.00%-5982.72%
EBITDA-3.23M-19.49M-35.13M-78.05M-150.50M-12.46M-18.11M
EBITDA Margin-27.85%-93.91%-88.68%-433.77%-61682.38%-24912.00%-5590.74%
Net Income-5.27M-20.20M-38.80M-93.14M-159.96M-55.98M-20.56M
Net Income Margin-45.38%-97.35%-97.94%-517.65%-65555.74%-111962.00%-6345.06%
R&D--5.96M10.71M103.76M472.00K-
R&D as % of Total Revenue--15.05%59.55%42525.82%944.00%-
Interest Expense165.14K551.00K2.34M4.88M7.43M52.00K1.17M
Interest Expense % of Total Revenue1.42%2.66%5.91%27.13%3043.44%104.00%362.35%

Balance Sheet

Currency: SEK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets76.60M127.19M193.44M192.65M39.05M11.64M9.63M
Total Liabilities14.12M37.64M30.26M101.50M62.17M13.07M17.14M
Total Equity62.48M89.55M132.50M91.15M-23.12M-1.43M-7.51M
Cash4.04M20.82M73.46M14.55M1.66M2.71M1.42M
Total Debt4.19M3.96M4.72M52.44M20.25M8.70M14.44M
Net Debt146.67K-16.86M-69.76M37.89M18.58M5.98M13.02M

Cash Flow

Currency: SEK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.88M-16.83M-26.05M-47.73M-41.80M-37.37M-21.49M
Investing Cash Flow5.99M-26.83M-26.77M-42.94M-20.84M-16.80M-
Financing Cash Flow2.13M58.91M106.02M32.73M49.00M55.23M20.19M
Capital Expenditure2.04M26.83M26.77M42.94M20.84M16.80M15.60M
Free Cash Flow-5.92M-43.66M-52.82M-90.67M-62.64M-54.17M-21.49M
FCF to OCF152.62%259.42%202.75%189.96%149.86%144.96%100.00%

Earnings

Report DateMar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020May 5, 2021Jun 30, 2021Sep 30, 2021Feb 17, 2022May 5, 2022Aug 24, 2022Nov 25, 2022Feb 16, 2023May 26, 2023Aug 17, 2023Nov 13, 2023Feb 9, 2024May 28, 2024Aug 15, 2024Nov 7, 2024Feb 6, 2025May 20, 2025Aug 27, 2025Nov 13, 2025Feb 12, 2026May 14, 2026Aug 26, 2026
EPS Estimate------------1800.00--------------
EPS Actual-280.23-28.31-68.59-189.14-0.60-236.39-269.28-0.23-0.22-0.29-0.34-2340.00-0.19-0.05-0.01-0.11-0.01-10.85-0.01-0.00-0.73-0.62-0.72-0.19-0.72-0.24
Surprise------------30.00%--------------
Timing-------Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-----

Key Statistics & Ratios

Market Cap46.20M
Enterprise Value52.91M
Trailing P/E0.00
Forward P/E0.00
Price / Sales53.47
Price / Book18.46
EPS-1.39
Book Value0.092
Revenue (TTM)864.00K
Gross Profit (TTM)447.00K
EBITDA-17.89M
Profit Margin0.00%
Operating Margin-692.03%
Return on Equity-2687.00%
Return on Assets-109.07%
Shares Outstanding28.87M
Shares Float26.10M
Beta0.60
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Mar 2, 2026406:403
  • Feb 6, 2025561:556
  • Jul 30, 20241:2000
  • Feb 7, 2024925:577
  • Apr 4, 2023572:147
  • Sep 28, 2022852:751